Publications

5674 Results

Prognostic factor analyses of myeloma survival with intergroup trial S9321 (INT 0141): examing whether different variables govern different time segments of survival [PMID21153898;PMC3053415]

Authors
B Barlogie;V Bolejack;M Schell;J Crowley
Journal / Conference
Annals of Hematology 90(4):423-428
Year
2011
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9321

Effect of vitamin E and selenium on F2-isoprostanes, a biomarker of oxidative stress

Authors
KA Guertin;RK Grant;AR Kristal;KB Arnold;JJ Crowley;JA Hartline;PJ Goodman;CM Tangen;LM Minasian;SM Lippman;EA Klein;PA Cassano
Journal / Conference
North American Congress of Epidemiology, 3rd annual meeting (6/21-24/11 Montreal), poster presentation;
Year
2011
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000C

The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704 [PMID20934270; PMC3038247]

Authors
TN Showalter;KA Winter;AC Berger;WF Regine;RA Abrams;H Safran;JP Hoffman;AB Benson;JS Macdonald;CG Willett
Journal / Conference
International Journal of Radiation Oncology Biology Physics 81(5):1328-1335
Year
2011
Research Committee(s)
Gastrointestinal
Study Number(s)
R9704

American Society of Clinical Oncology executive summary ofthe clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer [PMID 21343561]

Authors
CH Van Posnak;S Temin;NA Janian;WE Barlow;JS Bierman;LD Bosserman;C Geoghegan;BE Hillner;RL Theriault;DS Zuckerman;JH Von Roenn
Journal / Conference
Journal of Clinical Oncology 29(9):1221-1227
Year
2011
Research Committee(s)
Breast

Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group [PMID20878269]

Authors
RD Rao;M Cobleigh;R Gray;ML Graham;L Norton;S Martino;GT Budd;JN Ingle;WC Wood
Journal / Conference
Medical Oncology 28 Suppl 1:S39-47;
Year
2011
Research Committee(s)
Breast
Study Number(s)
SWOG-9514 (EB193)

Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial[PMID21300930; PMC3083866]

Authors
PA Ganz;SR Land;CE Geyer;RS Cecchini;JP Costantino;ER Pajon;L Fehrenbacher;JA Atkins;JA Polikoff;VG Vogel;JK Erban;RB Livingston;EA Perez;EP Mamounas;N Wolmark;SM Swain
Journal / Conference
Journal of Clinical Oncology 29(9):1110-1116
Year
2011
Research Committee(s)
Breast

Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial. PMID21335507; PMC3070045

Authors
A Kristal;C Till;E Platz;X Song;I King;M Neuhouser;C Ambrosone;IM Thompson
Journal / Conference
Cancer Epidemiology Biomarkers Prevention 20(4):638-646
Year
2011
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Finasteride reduces the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial

Authors
JK Parsons;J Schenk;K Arnold;K Messer;C Till;IM Thompson;A Kristal
Journal / Conference
AUA Annual Meeting, accepted, oral, late-breaking
Year
2011
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

SWOG S0215: A phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast [PMID21826527;PMC3513946]

Authors
R Livingston;W Barlow;J Kash;K Albain;J Gralow;D Lew;L Flaherty;ME Royce;GN Hortobagyi
Journal / Conference
Breast Cancer Research and Treatment 130(1):123-131;
Year
2011
Research Committee(s)
Breast
Study Number(s)
S0215

Measuring the performance of markers for guiding treatment decisions [PMID21320940; PMC3085402]

Authors
H Janes;J Pepe;W Barlow
Journal / Conference
Annals of Internal Medicine 154(4):253-259, 2011
Year
2011
Research Committee(s)
Multiple sites